Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 30 years of age or older at the time of signing up
- People who identify as Black and/or African American, OR people of any race or ethnicity who have a close family member (parent, sibling, or child) who has been diagnosed with a plasma cell disorder, such as MGUS, smoldering multiple myeloma, multiple myeloma, solitary plasmacytoma, plasma cell leukemia, AL amyloidosis, POEMS syndrome, or Waldenström's Macroglobulinemia
- People who are able and willing to give their informed consent to participate
- People who live in Charlotte, NC, or the surrounding area (based on self-report)
- For the longer-term follow-up part of the study: people who test positive for a monoclonal gammopathy (an abnormal protein in the blood) during the screening part of the study, and who agree to continue participating
Who may not be able to join:
- People who already have a personal history of MGUS, smoldering multiple myeloma, multiple myeloma, AL amyloidosis, plasma cell leukemia, solitary plasmacytoma, Waldenström's Macroglobulinemia, or POEMS syndrome
- For the longer-term follow-up part of the study: people who previously took part in the CHAAMP Internal Pilot study and completed diagnostic testing at that time without receiving a diagnosis of MGUS, smoldering multiple myeloma, or a related plasma cell disorder
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Manisha Bhutani, MD, Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Phone: 704-754-3768
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants who were Enrolled
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.